Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum
eBook - ePub

Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum

About this book

This open access book is written by world-renowned experts on radiomolecular precision oncology to celebrate the work, life, principles and ideology of Richard P Baum.
It includes commentaries, reviews and some thought provoking novel ideas on radionuclide precision oncology, covering topics such as various aspects of theranostics and molecular radiotherapy like radiolabeled peptides, radiolabeled antibodies, dosimetry, and quality control as well as the diagnosis and treatment of specific tumor types. Featuring contributions by biologists, physicists, chemists, mathematicians, geneticists, and physicians from a range of specialties, this Festschrift is highly interdisciplinary and will be a valuable resource for future precision oncologists.  

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum by Vikas Prasad in PDF and/or ePUB format, as well as other popular books in Médecine & Médecine interne et diagnostic. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Springer
Year
2024
Print ISBN
9783031335327
eBook ISBN
9783031335334

Table of contents

  1. Cover
  2. Front Matter
  3. 1. Rise of the Theranostics Empire: A Commentary on Dr. Baum’s Achievements
  4. 2. Review of F-18 FDG PET/CT in Evaluating Response to Immunotherapy Treatment
  5. 3. Surgery in Combination with Peptide Receptor Radionuclide Therapy: A Novel Approach for the Treatment of Advanced Neuroendocrine Tumours
  6. 4. From Concept to Clinic and Commercialization: Cowboys Wanted
  7. 5. From Radiochemistry of the Lanthanides to 225Ac and the Interference with Richard Baum
  8. 6. “How Do You Feel About Dosimetry?” The Gretchenfrage of Radionuclide Therapy
  9. 7. The LuGenIum Triptych: Ode to a Theranostic Transcriptome
  10. 8. A Tree Can Be Recognized by Its Fruit
  11. 9. IAEA Strategy for Enhancing the Sustainability of Nuclear Medicine in Low- and Middle-Income Countries
  12. 10. Radionuclide Therapy in Brain Tumours
  13. 11. Modern Diagnostic and Therapeutic Approaches in Thyroid Diseases: Theranostics and the Changing Role of Radioactive Isotopes
  14. 12. Cardiotoxicity of Targeted Therapies: Imaging of Heart Does Matter
  15. 13. The Evolution of n.c.a. 177Lu to n.c.a. 177Lu-Edotreotide for the Treatment of Neuroendocrine Tumours. Sixteen Years of Collaboration Between Zentralklinik Bad Berka and ITM
  16. 14. Fighting for PET in German Oncological Guidelines and for Its Reimbursement by Statutory Health Insurances
  17. 15. Precision Oncology with PSMA-Targeted α-Particle Therapy of mCRPC
  18. 16. From Radioimmunodetection to Radiomolecular Precision Oncology Via Radionanotargeting by Intelligent Multidisciplinary Radiotheragnostic Nanoparticles
  19. 17. Nuclear Medicine and Surgery on the Way to Personalized Medicine. Ten Years of Clinical and Translational Oncology and Research
  20. 18. PSMA Radioligand Therapy: A Revolution in the Precision Radiomolecular Oncology of Prostate Cancer
  21. 19. The Role of Individuals for Innovation: The Nuclear Medicine Biotope
  22. 20. Working at Isotopentherapiestation D3: A Daily Challenge or Adventure Never Stops
  23. 21. Theranostics in Australia: The Importance of Vision and Training, and the Power of Collaboration
  24. 22. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation
  25. 23. Terbium “Sisters”: More Than just a “Swiss Army Knife”
  26. 24. High-Performance Radiopharmacy: The Base for Precision Oncology
  27. 25. Analyzing the Science Footprint of Richard P. Baum
  28. 26. Therapy of Castration-Resistant Prostate Cancer: Where Is the Place of 225Ac-PSMA?
  29. 27. Sola Dosis Facit Venenum: Dosimetry for Molecular Radiotherapy in Bad Berka
  30. 28. On the Use of 203Pb Imaging to Inform 212Pb Dosimetry for 203/212Pb Image-Guided Alpha-Particle Therapy for Cancer
  31. 29. Radioiodine-Labeled Meta-Iodobenzylguanidine for Imaging and Treatment of Pheochromocytoma/Paraganglioma and Neuroblastoma
  32. 30. A (188)Rejuvenating Journey with Hercules
  33. 31. CXCR4 Theranostics: A Potential Game Changer in Solid Tumors and Hematological Malignancies
  34. 32. Can VPAC-Targeted Cu-67-TP3805 Play a Theranostic Role for Prostate Cancer?: A Quest
  35. 33. Evaluation of Real-World Efficiency of 177Lu-PSMA Radioligand Therapy of Metastatic Prostate Cancer
  36. 34. Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in Primary Neuroendocrine Tumors, Metastases, and Normal Liver Tissue: Is There a Significant Difference?
  37. 35. Theranostics with Somatostatin Receptor Antagonists
  38. 36. Molecular In Vitro and In Vivo Diagnostics as the Impartible Basis of Multimodal Therapy Approaches in Precision Oncology
  39. 37. Molecular Imaging Platform and Radiopharmaceutical Translational Research on Peking University Cancer Hospital
  40. 38. Is It Possible to Target HER2 Using Affibody Receptor Radionuclide Therapy?